Computational Viral Strain Transition Prediction Network

The patent creates a computational copy of the expert assessment process through machine learning models trained on historical genomic data and expert scores. The model reproduces expert judgment patterns without requiring actual expert involvement, enabling rapid prediction while maintaining assessment accuracy.

The patent replaces the mechanical system of manual expert scoring and laboratory-based experimental assays with an automated computational system. The machine learning model processes genomic sequences algorithmically, substituting human expert analysis and physical experimentation with computational prediction.

The computational model serves as a scalable copy of the expert assessment process, capable of evaluating multiple strains simultaneously without additional resource requirements. Once trained, the model can assess unlimited numbers of genomic sequences at constant marginal cost.

The patent replaces resource-intensive manual expert review and laboratory experimentation with automated computational analysis. This substitution enables the system to scale from assessing a few strains to evaluating global surveillance data from thousands of sources without proportional increases in time or resources.

The patent performs preliminary action by training the machine learning model on extensive historical genomic data and expert assessments before deployment. This pre-training phase captures evolutionary patterns and expert judgment criteria, enabling the model to make accurate predictions without requiring additional data collection or expert involvement during actual prediction operations.

The model incorporates feedback mechanisms by training on historical expert scores and validation datasets, continuously refining its predictions to match observed outcomes. The system learns from past prediction accuracy and adjusts its computational approach to improve measurement precision while maintaining high-speed processing.